ENDRA Life Sciences (NASDAQ:NDRA) Posts Quarterly Earnings Results, Misses Estimates By $5.30 EPS

ENDRA Life Sciences (NASDAQ:NDRA) released its earnings results on Monday. The company reported ($9.40) EPS for the quarter, missing analysts’ consensus estimates of ($4.10) by ($5.30), Zacks reports.

ENDRA Life Sciences Price Performance

Shares of NDRA opened at $4.24 on Monday. The company has a 50-day moving average of $4.63 and a two-hundred day moving average of $5.97. The stock has a market cap of $2.27 million, a price-to-earnings ratio of 0.00 and a beta of 0.43. ENDRA Life Sciences has a one year low of $3.15 and a one year high of $875.00.

ENDRA Life Sciences Company Profile

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.